Core Insights - The topic of "Northwest University Vice President Fan Daidi becomes the richest person in Shaanxi" has gained significant attention on social media, highlighting the wealth of Fan Daidi and her husband Yan Jianya, who own two listed companies: Juzhi Biotechnology and Triangle Defense [2] - According to the 2025 Hurun Global Rich List, Fan Daidi and her husband have a combined net worth of 31.5 billion yuan, surpassing other notable figures in the region [2] Company Overview - Juzhi Biotechnology, founded in 2000, specializes in the research, production, and sales of recombinant collagen and other bioactive components, and was listed on the Hong Kong Stock Exchange in November 2022 [3][4] - Fan Daidi, a co-founder of Juzhi Biotechnology, served as the executive director until July 2023 and has a long-standing affiliation with Northwest University, where she has held various academic positions [3][4] Market Dynamics - The recombinant collagen market is experiencing rapid growth, with a projected market size increase from 18.5 billion yuan in 2022 to 108.3 billion yuan by 2027, reflecting a compound annual growth rate (CAGR) of 42.4% [4] - Both Juzhi Biotechnology and Jinbo Biotechnology are showing high growth rates, with Juzhi's revenue reaching 5.539 billion yuan in 2024, a year-on-year increase of 57.2%, while Jinbo's revenue grew by 84.92% to 1.443 billion yuan [5] Financial Performance - Juzhi Biotechnology reported an adjusted net profit of 2.152 billion yuan in 2024, up 46.5% year-on-year, while Jinbo's net profit surged by 144.27% to 732 million yuan [5] - Both companies maintain high gross margins, with Juzhi's gross margin at 82.09% and Jinbo's at 92.02% in 2024 [6] Competitive Landscape - The competition in the recombinant collagen sector is intensifying, with established players like Huaxi Biotechnology and Aimeike entering the market, alongside new entrants like Hangzhou Meiliu Biotechnology, which has significantly reduced production costs [6][9] - Juzhi Biotechnology's revenue heavily relies on its core brand, Kefu Mei, which accounts for over 80% of its revenue, and the company is increasingly dependent on online sales channels, which constituted 71.6% of total revenue in 2024 [6][7] Product Development Challenges - Juzhi Biotechnology has plans to enter the recombinant collagen injection market, with two products expected to be approved in 2024, but currently, its registration is limited to dressing products [7][8] - Jinbo Biotechnology has achieved breakthroughs in the third-class medical device sector, holding all three existing registrations for recombinant collagen medical devices in China, but also faces challenges with revenue concentration [8][9]

【大河财立方 记者 夏晨翔】近日，一则"西北大学新任副校长范代娣，持股市值达443亿元，晋升新一 任陕西首富"的消息引起广泛关注。 范代娣与丈夫严建亚共同打造的商业版图逐渐浮出水面，叠加其学术身份，瞬间成为舆论焦点。 西北大学官网显示的范代娣简历 西北大学官网显示，2025年4月，范代娣出任西北大学党委委员、常委、副校长。 在商业领域，范代娣与丈夫严建亚二人通过掌控巨子生物（02367.HK）和三角防务（300775.SZ）两家 上市公司，以及在产业链上下游的深入布局，已构建起横跨生物科技与国防军工的资本矩阵。 2000年，范代娣与严建亚在西安高新区共同创立了巨子生物。2022年11月，巨子生物在港交所主板上 市，成为"胶原蛋白第一股"。 在招股书中，范代娣为巨子生物联合创始人、执行董事兼首席科学官；其丈夫严建亚担任法定代表人、 董事长及总经理；女儿严钰博则担任巨子生物的董秘一职。 值得一提的是，2007年，西北大学与巨子生物共同组建陕西省生物材料与发酵工程技术研究中心，主要 研发方向为生物产品的发酵中试放大技术、生物医用材料的研究与开发、组织工程的研究与开发等。 组建时，身为西北大学化工学院副院长的范代娣兼 ...

Market Overview - The U.S. stock market benefited significantly from positive news, with the market capitalization of the "Tech Giants" increasing by $837.5 billion (approximately 6 trillion RMB), marking the largest increase since April 9 [1] - The Hong Kong stock market experienced a decline, with the Hang Seng Index closing down 1.87% [1] - Goldman Sachs has postponed its interest rate cut expectations to December, while Citigroup has pushed its forecast from June to July [1] Shipping Industry Insights - The shipping market is expected to see freight rates rise by 20% in the short term, driven by increased demand for inventory replenishment ahead of potential uncertainties in trade negotiations [3] - The European shipping index futures surged over 10%, indicating strong market sentiment and potential for increased shipping activity [2][3] Investment Opportunities - Gold prices rebounded, with spot gold reaching $3,250, reflecting market sentiment amid ongoing trade tensions [2] - Companies in the shipping sector, such as Orient Overseas International and Yang Ming Marine Transport, have seen stock price increases of over 5% due to favorable market conditions [3] Industry Developments - The solar silicon industry is experiencing a supply-demand imbalance, with major manufacturers discussing production cuts to stabilize prices [7] - The price of polysilicon futures has risen significantly, increasing over 13% from recent lows, indicating a potential recovery in the solar sector [7] Company Performance - Goldwind Technology reported a 35.72% year-on-year increase in revenue for Q1 2025, with net profit rising by 70.84% [8] - The company has a robust order backlog of 51,091 MW, with a growing share of overseas orders, indicating strong market demand [9]

作为一名搞科研出身的女创业者，范代娣是产学研融合过程中的一次成功尝试。 文|王 嫱 近日，有媒体报道称，"西北大学新任副校长范代娣，持股市值达443亿元，晋升为新一任陕西首富"。 关于这一结论，报道的依据是"范代娣和丈夫严建亚名下的巨子生物、三角防务两家上市公司，总市值近900亿元，分 别处于医药生物和航空航天两大领域"。 但截至5月12日收盘，巨子生物市值为836亿港元(约合人民币773亿元)，三角防务市值为147亿元，因此范代娣及严建 亚合计持股市值达457亿元。 值得一提的是，在出任西北大学副校长前，范代娣已从相关公司退出。目前，范代娣本人在巨子生物、三角防务未担 任职务，亦不在主要股东之列。 所以，所谓的"陕西首富"纯属乌龙。 但作为一名搞科研出身的女创业者，范代娣的人生确实精彩。 从农家女到女学霸 据《科技日报》报道，1966年1月，范代娣出生于陕西蒲城。父亲是自学成才的赤脚医生。好多个夜晚，她都被上门求 医的敲门声惊醒，父亲也经常半夜出诊，回来给她讲述治好病人的喜悦，或患者病痛辞世的无奈。 据《中国青年报》报道，1984年，范代娣从家乡陕西蒲城考入西北大学化学工程系，在这里度过了本科和硕士的学习 ...

Investment Rating - The industry investment rating is "Overweight" [1] Core Insights - The report highlights the active research in life sciences and the global wave of biotechnology revolution, which is providing new solutions to major challenges such as health, climate change, resource security, and food security. The National Development and Reform Commission has issued the "14th Five-Year Plan for Biological Economy Development," indicating a trillion-yuan market potential in the biological economy [3][4]. Summary by Sections 1. Industry Market Dynamics - The synthetic biology sector has seen a decline of 8.90% in the recent week, ranking 32nd among various sectors [15]. - The synthetic biology index, which includes 58 companies, has underperformed compared to the Shanghai Composite Index and the ChiNext Index by 10.82% and 12.17%, respectively [4]. 2. Company Business Progress - Tianjin University has established the first synthetic biology and biomanufacturing college in China, aiming to cultivate innovative talents in response to the biotechnology revolution [7]. - Kasei Biotech and South Korea's 3P.COM have jointly established Hefei Hydrogen He New Materials Co., focusing on bio-based materials technology [8]. - The report mentions several projects and collaborations, including a biomass-based project by Luzhou Tianhua and Shanxi Coal Chemical Institute, and a partnership between Bio Island Laboratory and Wanhua Chemical [22][23]. 3. Industry Financing Tracking - The report notes an acceleration in financing for synthetic biology companies, with nearly a hundred companies completing new financing rounds since the beginning of 2025. For instance, Suzhou Yulu Qianxing Biotechnology completed several million yuan in Series A financing [27]. - Atlas Data Storage has raised $150 million in seed funding, setting a new record in the field, focusing on DNA storage technology [29].

Group 1 - Baidu Maps has been criticized for embedding ads that affect driving safety, with users reporting that ads obstruct navigation instructions, potentially leading to dangerous situations [1] - The advertising collaboration for Dongpeng Drink on Baidu Maps is expected to exceed 10 million RMB, raising concerns about compliance with internet advertising regulations [1] Group 2 - Hema has been officially sentenced for selling counterfeit L'Oreal and Estée Lauder products, with the main supplier facing a five-year prison term and the total amount involved being 3.22 million RMB [4] - Initially, Hema denied the allegations but later softened its stance as regulatory authorities intervened, leading to some consumer compensation [4] Group 3 - Kudi Coffee has announced an extension of its store subsidy policy until the end of 2028, introducing additional support for stores facing high rent and low sales volume [6] - The new policy aims to lower profitability thresholds in lower-tier markets and encourage franchisees to open stores in key business districts [6] Group 4 - The daughter of Jin Gui Zi achieved sales exceeding 10 million RMB in 30 days through live streaming, responding to criticisms about leveraging her mother's fame [7] - Data indicates that her Douyin account had a total sales volume of 1 million to 2.5 million RMB from 13 live streams [7] Group 5 - The new vice president of Northwest University, Fan Dai Di, has become the richest person in Shaanxi with a net worth exceeding 45.7 billion RMB, primarily from holdings in two listed companies [10][11] - Fan Dai Di is noted for her contributions to collagen protein research and the establishment of a biotechnology company [10] Group 6 - The US and China have announced a significant reduction in tariffs, with US tariffs on Chinese goods dropping from 145% to 30% and Chinese tariffs on US goods decreasing from 125% to 10% over the next 90 days [13] - This temporary agreement is seen as a potential easing of tensions between the two countries, with global stock markets reacting positively [13] Group 7 - A report indicates that the application rate of AI in Chinese workplaces is as high as 93%, significantly above the global average, with half of the users applying AI tools regularly [16] - However, there are concerns about misuse of AI, with a high percentage of Chinese respondents admitting to inappropriate use of AI tools for sensitive data [17]

Group 1 - The core viewpoint of the article highlights the rapid growth and significant market presence of Juzhi Biotechnology, which has become the largest beauty and skincare company in Hong Kong with a market capitalization exceeding 700 billion HKD [2] - The company achieved a remarkable gross profit of 4.5 billion CNY and a gross profit margin of 82.09%, earning the title of "medical beauty leader" [2] - The family of Fan Daidi has a strong influence on the company's management, with several key executives being relatives, indicating a concentrated control over the company's operations [2] Group 2 - Juzhi Biotechnology's performance has significantly boosted the wealth of Fan Daidi and her husband Yan Jianya, making them the new richest individuals in Shaanxi with a holding market value of 457 billion CNY [2][9] - The company has shown impressive revenue growth, with projected revenues of 3.524 billion CNY and 5.539 billion CNY for 2023 and 2024, respectively, alongside net profits of 2.947 billion CNY and 4.547 billion CNY [4] - The couple's wealth explosion began in 2022 with the IPO of Juzhi Biotechnology, which raised 4.6 billion HKD and distributed 2.3 billion HKD in dividends, with the family expected to receive 1.3 billion HKD [4] Group 3 - The family's investment strategy includes diversifying into sectors such as medical beauty, aerospace, and new materials, indicating a long-term vision for capital growth [2] - Yan Jianya has established a reputation as a prominent investment operator in the regional capital market, actively participating in various investment projects [5][6] - The couple's investment activities extend to the establishment of new companies and partnerships, such as the creation of Xi'an Santrong Aviation Technology Co., which received significant investment from local state-owned enterprises [7][8]

Core Viewpoint - The article discusses the rapid growth and wealth accumulation of the couple Fan Daidi and Yan Jianya, who have successfully positioned themselves in the beauty and aerospace industries through their company, Juzhi Biological, which has become a leading player in the Hong Kong stock market. Group 1: Company Performance - Juzhi Biological has seen a remarkable market performance, becoming the largest beauty and skincare company in Hong Kong with a market capitalization of 883 billion HKD as of May 13 [2] - The company achieved a gross profit of 4.5 billion RMB with a gross margin of 82.09%, earning the nickname "Medical Beauty King" [2] - In 2023 and 2024, Juzhi Biological is projected to achieve revenues of 3.52 billion RMB and 5.53 billion RMB, respectively, with net profits of 2.94 billion RMB and 4.54 billion RMB [15] Group 2: Family Business Structure - The management team of Juzhi Biological includes several family members, such as their daughter Yan Yubo, who holds multiple executive roles [4] - The couple has a significant influence over the company, controlling over 20% of the shares, which allows them to maintain substantial decision-making power [11] Group 3: Wealth Accumulation - The couple's wealth surged following the IPO of Juzhi Biological in November 2022, which has been a catalyst for their financial success [14] - As of May 13, the combined market value of Juzhi Biological and Triangle Defense is close to 1 trillion RMB, positioning them as the new richest couple in Shaanxi [29] Group 4: Investment Strategy - The couple is actively pursuing investments in various sectors, including medical beauty, aerospace, and new materials, indicating a strategic expansion of their business interests [5] - Yan Jianya has been involved in multiple investment initiatives, including a significant personal investment in Baotai Co., which highlights his role as a prominent player in the regional capital market [19][20]

据智通财经报道，近日，有媒体报道称："西北大学新任副校长范代娣，持股市值达443亿元，晋升为新一任 陕西首富。"关于这一结论，该报道给出的依据是"范代娣和丈夫严建亚名下的巨子生物、三角防务两家上市 公司，总市值近900亿元，分别处于医药生物和航空航天两大领域。" 资料图 （来源：极目新闻） 此后几年间，她历任西北大学副教授、教授、博士生导师、化工学院副院长、化工学院院长岗位。 今年4月3日，陕西省政府官网发布人事任免通知，任命范代娣为西北大学副校长（试用期一年）。 极目新闻综合智通财经、每日经济新闻等 据媒体报道，截至5月12日收盘，巨子生物市值为836亿港元（约合人民币773亿元），三角防务市值为147亿 元。按5月12日收盘价计算，范代娣及严建亚合计持股市值达457亿元。 换言之，上述财富系范代娣、严建亚夫妇共同所有。 工商信息及相关公司公告显示，在出任西北大学副校长前，范代娣已从相关公司退出。目前，范代娣本人在 巨子生物、三角防务未担任职务，亦不在主要股东之列。 据每日经济新闻报道，范代娣，陕西知名企业家，港股巨子生物的创始人之一，今年59岁。她的人生命运和 经历与西北大学深度交织。 1984年，范代娣 ...

Market Overview - On May 13, Hong Kong's three major indices collectively declined, with the Hang Seng Index falling by 1.87%, the Hang Seng China Enterprises Index down by 2.02%, and the Hang Seng Tech Index decreasing by 3.26% [1] Sector Performance - The Apple-related stocks experienced significant declines, including: - Highway Electronics (01415.HK) down 7.69% - Sunny Optical Technology (02382.HK) down 7.64% - BYD Electronics (00285.HK) down 7.11% - AAC Technologies (02018.HK) down 3.07% - Q Tech (01478.HK) down 3.41% [1] - The automotive supply chain, including lithium batteries and Tesla-related stocks, also saw declines: - Jinli Permanent Magnet (06680.HK) down 4.88% - Xpeng Motors-W (09868.HK) down 5.35% - NIO-SW (09866.HK) down 5.17% - Xiaomi Group-W (01810.HK) down 3.85% - Li Auto-W (02015.HK) down 3.05% [1] - Semiconductor stocks faced notable declines: - Hua Hong Semiconductor (01347.HK) down 4.24% - SMIC (00981.HK) down 4.05% - Beike Micro (02149.HK) down 2.86% - Shanghai Fudan (01385.HK) also declined [1] Technology Sector - Technology-related stocks, including short video concepts, cloud office, and cloud computing, mostly weakened: - Weimob Group (02013.HK) down 5.52% - Kuaishou-W (01024.HK) down 4.62% - Bilibili-W (09626.HK) down 3.14% - Alibaba-W (09988.HK) down 3.89% - NetEase-S (09999.HK) down 2.96% - Kingsoft Cloud (03896.HK) down 5.91% [2] - Other consumer sectors, including holiday concepts, sports goods, home appliances, and beer, also saw declines: - Meituan-W (03690.HK) down 4.91% - China Resources Beer (00291.HK) down 4.63% - Hisense Home Appliances (00921.HK) down 2.33% [2] Biopharmaceutical Sector - The biopharmaceutical and medical aesthetics sectors showed resilience, with notable gains: - Kintor Pharmaceutical-B (02171.HK) up 14.94% - Peijia Medical-B (09996.HK) up 9.2% - Yiming Oncology-B (01541.HK) up 7.77% - Genscript Biotech (02367.HK) up 5.64% [2] Gold Sector - The gold sector saw gains in the afternoon, with significant increases: - Tongguan Gold (00340.HK) up 15.79% - Chifeng Jilong Gold Mining (06693.HK) up 5.19% - Lingbao Gold (03330.HK) up 5.37% - Shandong Gold (01787.HK) up 4.75% - China Gold International (02099.HK) up 4.26% - Zhaojin Mining (01818.HK) up 3.45% [3] - The international gold price rebounded, influenced by uncertainties in U.S. macroeconomic policies and inflation concerns, which may support gold prices throughout the year [3]